Literature DB >> 11849130

Review article: Helicobacter pylori and nonulcer dyspepsia.

N J Talley1, C Quan.   

Abstract

Although up to 50% of patients diagnosed with nonulcer dyspepsia (NUD) have Helicobacter pylori infection and underlying chronic gastritis, it remains controversial whether any causal relationship exists. The results of worldwide epidemiological studies have been unconvincing. No clear-cut link has been documented between H. pylori and any specific symptom profile or pathophysiological mechanism in NUD. In the randomized controlled trials, methodological weaknesses may explain in part the conflicting results, but even in the well-conducted trials controversy persists. Although meta-analyses have attempted to resolve the issue, inherent methodological difficulties with meta-analysis remain a problem. Moreover, even the methodologically sound meta-analyses have reported conflicting results. In addition, predictors of treatment response remain obscure, and there continue to be theoretical concerns about the treatment of H. pylori infection in all patients with NUD. Hence, the management of these patients is challenging, but eradication of H. pylori infection may be beneficial in a small subgroup of cases with NUD that cannot be identified before treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11849130     DOI: 10.1046/j.1365-2036.2002.0160s1058.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Direct measurement of gastric H+/K+-ATPase activities in patients with or without Helicobacter pylori-associated chronic gastritis.

Authors:  Duangporn Thong-Ngam; Pisit Tangkijvanich; Pichet Sampatanukul; Paungpayom Prichakas; Varocha Mahachai; Piyaratana Tosukowong
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Treatment of functional dyspepsia.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

3.  Functional Dyspepsia: A New Rome III Paradigm.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

4.  Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.

Authors:  Yiqi Du; Zhaoshen Li; Xianbao Zhan; Jie Chen; Jun Gao; Yanfang Gong; Jianlin Ren; Liping He; Zhijian Zhang; Xiaozhong Guo; Jianshen Wu; Zibin Tian; Ruihua Shi; Bo Jiang; Dianchun Fang; Youming Li
Journal:  Dig Dis Sci       Date:  2008-02-21       Impact factor: 3.199

5.  Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study.

Authors:  Anne Mette Asfeldt; Bjørn Straume; Sonja Eriksson Steigen; Maja-Lisa Løchen; Jon Florholmen; Bjørn Bernersen; Roar Johnsen; Eyvind J Paulssen
Journal:  Eur J Epidemiol       Date:  2008-08-14       Impact factor: 8.082

6.  An Evidence-Based Approach to the Management of Functional Dyspepsia Associated With Helicobacter pylori Infection.

Authors:  Shou-Wu Lee; Yen-Chun Peng; Chun-Fang Tung; Teng-Yu Lee; Chi-Sen Chang; Hong-Zen Yeh
Journal:  Gastroenterology Res       Date:  2014-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.